Allergan: Application published: “Two Part Formulation System for Ophthalmic Delivery”

July 27, 2017: The USPTO today published a patent application filed by Allergan, Inc. of Irvine, CA: U.S. Application Publication No. 2017/0209532, “Two Part Formulation System for Ophthalmic Delivery”.

According to the published abstract:

Ophthalmic products and related methods are described herein. These methods include a stabilizing composition comprising a therapeutically active agent which is separated from a liquid vehicle composition by a barrier. The barrier may be removed to allow the two compositions to mix to provide an ophthalmically acceptable liquid comprising the therapeutically active agent.

The published application can be viewed at the USPTO website at http://pdfaiw.uspto.gov/.aiw?Docid=20170209532.

Note: A published application is not an issued patent. The USPTO automatically publishes most applications 18 months after filing, and the publication is simply a copy of the as-filed application, without examination.